zonegran zonisamide 100mg capsule blister pack
amdipharm mercury australia pty ltd - zonisamide, quantity: 100 mg - capsule, hard - excipient ingredients: allura red ac; sodium lauryl sulfate; hydrogenated vegetable oil; titanium dioxide; microcrystalline cellulose; sunset yellow fcf; gelatin; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - zonegran is indicated as: - monotherapy in the treatment of partial seizures, with or without secondary generalisation, in adults with newly diagnosed epilepsy who are intolerant to other agents or where other agents are contraindicated. - adjunctive therapy in the treatment of adult patients with partial seizures, with or without secondary generalisation.
zonegran zonisamide 50mg capsule blister pack
amdipharm mercury australia pty ltd - zonisamide, quantity: 50 mg - capsule, hard - excipient ingredients: titanium dioxide; microcrystalline cellulose; sodium lauryl sulfate; gelatin; iron oxide black; hydrogenated vegetable oil; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; potassium hydroxide - zonegran is indicated as: - monotherapy in the treatment of partial seizures, with or without secondary generalisation, in adults with newly diagnosed epilepsy who are intolerant to other agents or where other agents are contraindicated. - adjunctive therapy in the treatment of adult patients with partial seizures, with or without secondary generalisation.
zonegran zonisamide 25mg capsule blister pack
amdipharm mercury australia pty ltd - zonisamide, quantity: 25 mg - capsule, hard - excipient ingredients: gelatin; microcrystalline cellulose; hydrogenated vegetable oil; titanium dioxide; sodium lauryl sulfate; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - zonegran is indicated as: - monotherapy in the treatment of partial seizures, with or without secondary generalisation, in adults with newly diagnosed epilepsy who are intolerant to other agents or where other agents are contraindicated. - adjunctive therapy in the treatment of adult patients with partial seizures, with or without secondary generalisation.
diabex xr 500 metformin hydrochloride 500mg extended release tablet blister pack
alphapharm pty ltd - metformin hydrochloride, quantity: 500 mg - tablet, modified release - excipient ingredients: hypromellose; magnesium stearate; microcrystalline cellulose; carmellose sodium - treatment of type 2 diabetes mellitus in adults, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control. diabex xr 500 may be used as monotherapy or in combination with other oral antidiabetic agents, or with insulin.
diabex xr 500 metformin hydrochloride 500 mg extended release tablet blister pack
alphapharm pty ltd - metformin hydrochloride, quantity: 500 mg - tablet, modified release - excipient ingredients: hypromellose; magnesium stearate; carmellose sodium - treatment of type 2 diabetes mellitus in adults, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control. diabex xr 500 may be used as monotherapy or in combination with other oral antidiabetic agents, or with insulin.
proglutrol g2 sustained release tablet 2500mg
healol pharmaceuticals sdn. bhd. - glimepiride; metformin hydrochloride -
pharmacor metformin xr 500 metformin hydrochloride 500 mg extended release tablet blister pack
pharmacor pty ltd - metformin hydrochloride, quantity: 500 mg - tablet, modified release - excipient ingredients: carmellose sodium; copovidone; magnesium stearate; hypromellose; microcrystalline cellulose - metformin is indicated in the treatment of type 2 diabetes mellitus in adults, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control. metformin hcl extended release tablets may be used as monotherapy or in combination with other oral antidiabetic agents, or with insulin
pharmacor metformin xr 750 metformin hydrochloride 750 mg extended release tablet bottle pack
pharmacor pty ltd - metformin hydrochloride, quantity: 750 mg - tablet, modified release - excipient ingredients: carmellose sodium; magnesium stearate; copovidone; hypromellose; microcrystalline cellulose - metformin is indicated in the treatment of type 2 diabetes mellitus in adults, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control. metformin hcl extended release tablets may be used as monotherapy or in combination with other oral antidiabetic agents, or with insulin
diaxemet xr 500 metformin hydrochloride 500 mg extended release tablet bottle pack
pharmacor pty ltd - metformin hydrochloride, quantity: 500 mg - tablet, modified release - excipient ingredients: microcrystalline cellulose; magnesium stearate; carmellose sodium; copovidone; hypromellose - metformin is indicated in the treatment of type 2 diabetes mellitus in adults, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control. metformin hcl extended release tablets may be used as monotherapy or in combination with other oral antidiabetic agents, or with insulin
diaxemet xr 750 metformin hydrochloride 750 mg extended release tablet blister pack
pharmacor pty ltd - metformin hydrochloride, quantity: 750 mg - tablet, modified release - excipient ingredients: magnesium stearate; microcrystalline cellulose; hypromellose; carmellose sodium; copovidone - metformin is indicated in the treatment of type 2 diabetes mellitus in adults, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control. metformin hcl extended release tablets may be used as monotherapy or in combination with other oral antidiabetic agents, or with insulin